Skip to main content

Action Construction Equipments (ACE) [ Ready For The New Action]

Action Construction Equipment (ACE) Cmp:38


 A Delhi-based construction equipment manufacturer. The company was incorporated as a private limited company in 1995 and went public in 2005. Vijay Agarwal is the chairman, CEO, and managing director of the company. 

ACE is engaged in designing, manufacturing and marketing hydraulic mobile pick-n-move cranes, forklift trucks, loaders, tower cranes, aerial work platforms, mast climbing platforms/lifts, and lorry loaders/truck mounted cranes. ACE has full-fledged production facilities based in Faridabad. ACE equipment is used in many industrial sectors like infrastructure, construction, roads, engineering industry, coal mines, chemical and fertilizer plants, power stations, ports, heavy project engineering industry, railways, cement industry, oil industry, defence etc. 

ACE has been certified as an ISO 9001 company by CVI. The company has a series of tie-ups with the leading foreign companies like PM-Italy, Zoomlion-China, Maber-Italy and Airo-Italy, for technology and machines from around the world. The company`s Cyprus arm, Frested, acquired 73.9% stake in a Romanian company, SC FORMA SA-Romania, for a total cost of USD 2.15 million. 

ACE provides spares and support for construction equipments and has a network of five regional offices and 37 sales and service dealer outlets across India. Clients include Reliance Industries, Punj Lloyd, ACC, Cimmco Birla, Central Coalfields, Punjab State Electricity Board, Rajasthan State Electricity Board etc. ACE has marketing tie-ups with companies like Autogru PM, Tigieffe SRL and Maber in Italy and Zoomlion in China and also exports its equipment to the Middle East and African countries. 


A Leading Stock Brokers And Mumbai Big Hni Are Advice To Their Inner Circle To Buy Aci Some Big Action Are Wating For Making In This Counter Investor Can Buy This Share For Long Term Target 70 

Comments

Popular posts from this blog

Best Buy For Monday Upper Circuit Expected TCI FINANCE

*Intraday & Short Term News For Monday* *Fii And Dii News*   *TCI FINANCE LTD (501242 & NSE) (31)*   Incorporated in 1973, TCI Finance Ltd (TCIFL) is a Non-Banking Finance Company (NBFC) registered with the RBI and engaged in the business of Inter-Corporate Deposits, investment in equities of bodies corporate etc.   The Company was promoted by Mr. Mahendra Agarwal, who is also the Managing Director and CEO of Gati Ltd, a pioneer in express distribution and supply chain and promoted by TCFIL   The Rs.2 paid-up share of Gati Ltd currently trades at Rs.113. TCIFL has one subsidiary - ITAG Business Solutions Ltd engaged in the business of Knowledge Process Outsourcing (KPO) in the domain of Intellectual Property Services.   *It is co-promoter of GATI LTD. Company is holding 55,12,455 shares (5.09%) stake in GATI LTD. At CMP value of investments is around Rs.62.3crore. Equity is Rs.12.87crore. Thus value of investment works out to Rs.48.4 per share ...

Danlaw Technologies India Ltd: For multi-bagger gains (BSE Code: 532329) (CMP: Rs. 60.75) (FV: Rs.10)

The earnings season so far has been weak and worries over domestic growth continue to weigh on the market sentiment which has led the markets back on the downward path.. A value investor, however, need not worry about the broad markets as value stocks perform better and post good results. One such value-pick is Danlaw Technologies India Ltd. (DTIL). Company background: DTIL is the offshore technology and product development center of its parent company - Danlaw Incorporated, founded by Mr. Raju Dandu and Mr. Lloyd Lawrence in Michigan, USA in 1984. DTIL’s mission is to provide high quality services and products in Automotive Electronics, develop R&D driven Signal Processing technologies for communication and control, configure solutions and provide exceptional Information Technology (IT) services in the areas of education, health, banking and e-governance and provide world-class products and solutions for secured access through biometric access control technologies with intellige...

Some Opportunities Are left in Pharma Sector

Torrent Pharmaceuticals  reported impressive 75% growth in revenues and profit in the first quarter of FY 2016. The sterling performance was driven by the launch of new product in the US market, which has limited competition at present. The focus is on the therapeutic segments of cardiovascular and CNS. There is presence in gastro-intestinal, diabetology, anti-infective, pain management, nephrology, oncology, gynecology and pediatric segments as well. The manufacturing plants for formulations and bulk drugs have been approved by authorities of several regulated and semi-regulated markets such as the US, the UK, Brazil, Germany, Australia and South Africa. Capacity will increase almost 100% once the new plant at Dahej in Gujarat becomes operational. The plant will be one of the largest pharmaceuticals manufacturing facilities in the country at a single location. The unit will primarily cater to the key regulated markets of the US and Europe. Approval from regulators such...